» Articles » PMID: 22346447

Hepatitis C: Recent Advances

Overview
Date 2012 Feb 21
PMID 22346447
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Interferon-alpha in hepatitis C. Dosage, costs and benefits.

Briggs A, Shiell A Pharmacoeconomics. 1996; 10(3):205-9.

PMID: 10163569 DOI: 10.2165/00019053-199610030-00002.

References
1.
Di Bisceglie A, Shindo M, Fong T, Fried M, Swain M, Bergasa N . A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology. 1992; 16(3):649-54. DOI: 10.1002/hep.1840160307. View

2.
Lau J, Davis G, Kniffen J, Qian K, Urdea M, Chan C . Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 1993; 341(8859):1501-4. DOI: 10.1016/0140-6736(93)90635-t. View

3.
Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S . Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med. 1992; 116(1):21-5. DOI: 10.7326/0003-4819-116-1-21. View

4.
Seeff L, Wright E, Durako S, Alter H, Iber F, Hollinger F . Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med. 1992; 327(27):1906-11. DOI: 10.1056/NEJM199212313272703. View

5.
Weiner A, Kuo G, Bradley D, Bonino F, Saracco G, Lee C . Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet. 1990; 335(8680):1-3. DOI: 10.1016/0140-6736(90)90134-q. View